ID,Description,setSize,enrichmentScore,NES,pvalue,p.adjust,qvalues,ont,comparison
GO:0043410,positive regulation of MAPK cascade,478,0.328256625388011,1.5430937977346,0.003125,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0022604,regulation of cell morphogenesis,403,0.285747984654891,1.32088665241629,0.00316455696202532,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043434,response to peptide hormone,491,0.311918085719486,1.46767355842712,0.00318471337579618,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071375,cellular response to peptide hormone stimulus,416,0.322719670868592,1.50486782804653,0.00319488817891374,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032868,response to insulin,384,0.325155423329501,1.50814339333314,0.00320512820512821,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006897,endocytosis,497,0.300753300505393,1.42301706158912,0.00323624595469256,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1901653,cellular response to peptide,431,0.318166175526993,1.48356018980237,0.00323624595469256,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030029,actin filament-based process,498,0.320799928988659,1.52102306572588,0.00324675324675325,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032869,cellular response to insulin stimulus,345,0.326942867488658,1.49917750974552,0.00324675324675325,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009259,ribonucleotide metabolic process,388,0.308790321807113,1.43965671741977,0.00325732899022801,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0016055,Wnt signaling pathway,335,0.306331078136838,1.39794886379196,0.00325732899022801,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0019693,ribose phosphate metabolic process,400,0.3025655760033,1.40997107123192,0.00326797385620915,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030111,regulation of Wnt signaling pathway,245,0.361077151912823,1.60051721542355,0.00328947368421053,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050801,ion homeostasis,494,0.314301178386361,1.48456065668937,0.00328947368421053,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0098771,inorganic ion homeostasis,452,0.319284582613842,1.50289235964653,0.00328947368421053,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030036,actin cytoskeleton organization,439,0.319579862279739,1.49250116873297,0.0033003300330033,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032147,activation of protein kinase activity,385,0.301122661473327,1.39761131181196,0.0033003300330033,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071496,cellular response to external stimulus,220,0.341654256488364,1.47455845615941,0.0033003300330033,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006163,purine nucleotide metabolic process,394,0.308044360956713,1.44007530045744,0.0033112582781457,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0040017,positive regulation of locomotion,327,0.323524989159894,1.47152744858849,0.0033112582781457,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043623,cellular protein complex assembly,455,0.311604098128561,1.44825949046989,0.0033112582781457,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060828,regulation of canonical Wnt signaling pathway,192,0.376603931903146,1.64608650903879,0.0033112582781457,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0055082,cellular chemical homeostasis,497,0.298326088270507,1.41136871807676,0.00332225913621262,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0090066,regulation of anatomical structure size,365,0.34644176689971,1.59723385962593,0.00332225913621262,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903649,regulation of cytoplasmic transport,388,0.376011687725527,1.74363777372016,0.00332225913621262,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006576,cellular biogenic amine metabolic process,156,0.388355805777425,1.64153321805024,0.00334448160535117,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051249,regulation of lymphocyte activation,332,0.314816727576458,1.45499323157769,0.00334448160535117,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002694,regulation of leukocyte activation,380,0.311163046346611,1.44462310719087,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007159,leukocyte cell-cell adhesion,414,0.358117463747563,1.67738395564702,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009150,purine ribonucleotide metabolic process,374,0.31601420094963,1.46817538620072,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030099,myeloid cell differentiation,302,0.302180666779842,1.36998756222919,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043900,regulation of multi-organism process,420,0.294033975119216,1.38858457280872,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0048010,vascular endothelial growth factor receptor signaling pathway,254,0.444196691775722,1.96918173453152,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0055080,cation homeostasis,443,0.318436609360822,1.49074729914236,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071902,positive regulation of protein serine/threonine kinase activity,248,0.318159716993759,1.40792735158127,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0098542,defense response to other organism,409,0.38161676426022,1.79003237679895,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903034,regulation of response to wounding,304,0.371407042498144,1.67092957138211,0.00335570469798658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006909,phagocytosis,188,0.417714917175518,1.78925828502065,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007265,Ras protein signal transduction,397,0.328156699368089,1.52834190147994,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030335,positive regulation of cell migration,307,0.3405506156173,1.5449078214759,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032535,regulation of cellular component size,280,0.33997080181524,1.5277167928187,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043405,regulation of MAP kinase activity,394,0.326470638153425,1.5080820376456,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045088,regulation of innate immune response,361,0.391057988979629,1.78497914974545,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903320,regulation of protein modification by small protein conjugation or removal,279,0.326568925483349,1.47909555789742,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903827,regulation of cellular protein localization,474,0.320173858332105,1.50988485546813,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2000147,positive regulation of cell motility,314,0.335491133958019,1.52418284948925,0.00336700336700337,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009615,response to virus,345,0.361964969679831,1.6694696493359,0.00337837837837838,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030041,actin filament polymerization,134,0.401543558112822,1.63229698742777,0.00337837837837838,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030178,negative regulation of Wnt signaling pathway,151,0.445026736742412,1.85328905825283,0.00337837837837838,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050865,regulation of cell activation,406,0.315308506655551,1.4742358520894,0.00337837837837838,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051051,negative regulation of transport,366,0.338669198143954,1.56535368362497,0.00337837837837838,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051272,positive regulation of cellular component movement,323,0.336391548620663,1.5346431296777,0.00337837837837838,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0097193,intrinsic apoptotic signaling pathway,265,0.336884933402163,1.51056771781044,0.00337837837837838,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007411,axon guidance,427,0.367138401767969,1.72743054118516,0.00338983050847458,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009612,response to mechanical stimulus,161,0.35303717700595,1.47695218972658,0.00338983050847458,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042176,regulation of protein catabolic process,356,0.326186573068649,1.48938758668325,0.00338983050847458,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045785,positive regulation of cell adhesion,305,0.356770279275917,1.63271249732261,0.00338983050847458,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0055065,metal ion homeostasis,406,0.315593874201073,1.47483952157457,0.00338983050847458,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0097485,neuron projection guidance,427,0.367138401767969,1.72743054118516,0.00338983050847458,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007249,I-kappaB kinase/NF-kappaB signaling,246,0.385232602904625,1.68498917109933,0.00340136054421769,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031349,positive regulation of defense response,383,0.387608888912179,1.78671861107923,0.00340136054421769,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032970,regulation of actin filament-based process,254,0.363725367755884,1.61951476716293,0.00340136054421769,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050817,coagulation,460,0.392872561646832,1.85501288655068,0.00340136054421769,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071774,response to fibroblast growth factor,283,0.340494835219939,1.51730087275178,0.00340136054421769,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072593,reactive oxygen species metabolic process,200,0.372942671926842,1.58567587755354,0.00340136054421769,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007015,actin filament organization,261,0.374319358780009,1.65604399806425,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007596,blood coagulation,457,0.393632171195459,1.85668042436058,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009308,amine metabolic process,181,0.359187324939798,1.52683949671453,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042110,T cell activation,382,0.341354628709363,1.586367951932,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0044106,cellular amine metabolic process,175,0.353130745966744,1.50016223150186,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0070489,T cell aggregation,382,0.341354628709363,1.586367951932,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0097191,extrinsic apoptotic signaling pathway,201,0.343781343095691,1.49750141744643,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903530,regulation of secretion by cell,460,0.290333932471093,1.37044158782428,0.00341296928327645,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002253,activation of immune response,472,0.418279899440713,1.95321984462993,0.00342465753424658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002768,immune response-regulating cell surface receptor signaling pathway,451,0.369675904561477,1.72494938231303,0.00342465753424658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030833,regulation of actin filament polymerization,120,0.414513911316153,1.65620745338058,0.00342465753424658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031331,positive regulation of cellular catabolic process,299,0.319725991263875,1.44529649361854,0.00342465753424658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071593,lymphocyte aggregation,383,0.340284975906556,1.58174590190345,0.00342465753424658,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002758,innate immune response-activating signal transduction,265,0.395776113085096,1.76267319192417,0.00343642611683849,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0016049,cell growth,368,0.312967103634759,1.44218047577754,0.00343642611683849,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0033157,regulation of intracellular protein transport,323,0.359868312826764,1.6402004758265,0.00343642611683849,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051348,negative regulation of transferase activity,305,0.312471044795693,1.41983339045828,0.00343642611683849,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002697,regulation of immune effector process,358,0.370903702568283,1.7033695278635,0.00344827586206897,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002757,immune response-activating signal transduction,433,0.411933372231619,1.90778186286547,0.00344827586206897,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034109,homotypic cell-cell adhesion,436,0.370685757914868,1.73944122197763,0.00344827586206897,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007599,hemostasis,462,0.385571780925222,1.81693987467094,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009617,response to bacterium,400,0.34979379769222,1.62180528874172,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032388,positive regulation of intracellular transport,299,0.314094934001702,1.40365953952018,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,220,0.393997676315285,1.72031624095381,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045089,positive regulation of innate immune response,312,0.387868144099599,1.74536990031335,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0046822,regulation of nucleocytoplasmic transport,187,0.372490300749477,1.58701382407816,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051091,positive regulation of sequence-specific DNA binding transcription factor activity,184,0.366229197413658,1.5605401091201,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060326,cell chemotaxis,177,0.428401161494077,1.82459268127147,0.00346020761245675,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001558,regulation of cell growth,292,0.323578927421742,1.46321511681087,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002521,leukocyte differentiation,395,0.300447679857773,1.38735960080985,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0003013,circulatory system process,342,0.290452971499903,1.32364409845371,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0008154,actin polymerization or depolymerization,156,0.394846885581899,1.63585902875901,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0008286,insulin receptor signaling pathway,291,0.347025478289372,1.55291343785638,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031397,negative regulation of protein ubiquitination,143,0.428019177409712,1.7905988442525,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0038095,Fc-epsilon receptor signaling pathway,264,0.326385469696023,1.46310875395558,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045862,positive regulation of proteolysis,327,0.350674740107813,1.57535581759325,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050900,leukocyte migration,282,0.416892147477856,1.87665135994817,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051480,regulation of cytosolic calcium ion concentration,185,0.370465239228659,1.60666992522055,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2001233,regulation of apoptotic signaling pathway,333,0.326174824948209,1.47082723743835,0.00347222222222222,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002218,activation of innate immune response,271,0.400898247712951,1.78426269888917,0.00348432055749129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002431,Fc receptor mediated stimulatory signaling pathway,78,0.519129258495739,1.93978792634788,0.00348432055749129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002474,antigen processing and presentation of peptide antigen via MHC class I,102,0.52481437149655,2.11799051912896,0.00348432055749129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0022407,regulation of cell-cell adhesion,320,0.341457211208072,1.5734438730642,0.00348432055749129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0038093,Fc receptor signaling pathway,320,0.372455789087476,1.67633126971147,0.00348432055749129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051258,protein polymerization,196,0.389107189756476,1.65028149919289,0.00348432055749129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0070486,leukocyte aggregation,389,0.349307227163239,1.62438098507899,0.00348432055749129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002429,immune response-activating cell surface receptor signaling pathway,298,0.432094320122821,1.93512575268978,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002443,leukocyte mediated immunity,251,0.416523290094032,1.86553132470406,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002673,regulation of acute inflammatory response,52,0.533043157977841,1.86520790781303,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002696,positive regulation of leukocyte activation,254,0.349900319191816,1.56369890646545,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007204,positive regulation of cytosolic calcium ion concentration,176,0.387689832932472,1.66110651511907,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009161,ribonucleoside monophosphate metabolic process,227,0.363755726947212,1.61536720025413,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0038094,Fc-gamma receptor signaling pathway,76,0.531323354225747,1.95211066139754,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903050,regulation of proteolysis involved in cellular protein catabolic process,234,0.343674319979143,1.50487949949164,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1904951,positive regulation of establishment of protein localization,404,0.298661563154726,1.37916117043526,0.0034965034965035,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001819,positive regulation of cytokine production,340,0.334626303953027,1.5283381177397,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,197,0.431110809840597,1.87435071398387,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002683,negative regulation of immune system process,306,0.333426843188236,1.51306469473213,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0019932,second-messenger-mediated signaling,177,0.353621998472801,1.52656536491527,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032103,positive regulation of response to external stimulus,226,0.391757583536416,1.70703975282409,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032496,response to lipopolysaccharide,273,0.350556356749951,1.55969364054602,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034110,regulation of homotypic cell-cell adhesion,268,0.335860449667332,1.51928668266921,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043254,regulation of protein complex assembly,307,0.358925698266277,1.5994606672483,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0044089,positive regulation of cellular component biogenesis,320,0.331872400593325,1.49595187098282,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050867,positive regulation of cell activation,261,0.35179017560366,1.57679127957211,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0090090,negative regulation of canonical Wnt signaling pathway,128,0.443514534736619,1.80870638713182,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903321,negative regulation of protein modification by small protein conjugation or removal,151,0.391623034387859,1.63381644979044,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2000021,regulation of ion homeostasis,141,0.411169269160725,1.71211642484728,0.00350877192982456,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002449,lymphocyte mediated immunity,189,0.449623223239786,1.92920246992888,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002526,acute inflammatory response,104,0.453480532582199,1.78512571666435,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006873,cellular ion homeostasis,398,0.316314026133919,1.47131285797211,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030307,positive regulation of cell growth,114,0.364761999789825,1.46414621643422,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0038061,NIK/NF-kappaB signaling,101,0.468567760060903,1.87955385247322,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0044344,cellular response to fibroblast growth factor stimulus,279,0.342362338568363,1.51858210028062,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045333,cellular respiration,181,0.345324022207064,1.46232769585188,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051235,maintenance of location,240,0.353375892115543,1.55160465656377,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903362,regulation of cellular protein catabolic process,251,0.348206375565673,1.5355581915334,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2001057,reactive nitrogen species metabolic process,70,0.476443139948138,1.74469705880694,0.00352112676056338,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001910,regulation of leukocyte mediated cytotoxicity,44,0.539145357586556,1.86486083121261,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002237,response to molecule of bacterial origin,284,0.343568611572223,1.53722999467694,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006091,generation of precursor metabolites and energy,394,0.329869207823649,1.51887364379601,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006875,cellular metal ion homeostasis,359,0.306710845052715,1.42290541137049,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0008064,regulation of actin polymerization or depolymerization,136,0.423361807046418,1.72631185680717,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0015980,energy derivation by oxidation of organic compounds,322,0.312008810529053,1.40638900522636,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030003,cellular cation homeostasis,389,0.313778228276905,1.4581608256981,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031396,regulation of protein ubiquitination,259,0.354623780783693,1.59551719819944,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050920,regulation of chemotaxis,136,0.393701097941659,1.62870034692332,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051340,regulation of ligase activity,129,0.398414100474958,1.63824681232276,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072331,signal transduction by p53 class mediator,155,0.422760572977224,1.77703297724342,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903533,regulation of protein targeting,256,0.362278058158481,1.60690316800921,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903651,positive regulation of cytoplasmic transport,222,0.333211850707852,1.45375517855588,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903706,regulation of hemopoiesis,273,0.337984683078605,1.5267332313579,0.00353356890459364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002703,regulation of leukocyte mediated immunity,137,0.451860045804112,1.8889920047922,0.00354609929078014,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032956,regulation of actin cytoskeleton organization,229,0.358281890829816,1.56152127074884,0.00354609929078014,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045787,positive regulation of cell cycle,283,0.309125183463101,1.39663832441371,0.00354609929078014,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050663,cytokine secretion,144,0.39718216424081,1.67152744591103,0.00354609929078014,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050708,regulation of protein secretion,312,0.326199515165268,1.48190650221067,0.00354609929078014,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050729,positive regulation of inflammatory response,83,0.489921092623335,1.86922672870321,0.00354609929078014,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903037,regulation of leukocyte cell-cell adhesion,260,0.328661256982611,1.47579205679126,0.00354609929078014,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002478,antigen processing and presentation of exogenous peptide antigen,163,0.421650264051559,1.7876359198137,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009116,nucleoside metabolic process,329,0.327186626003391,1.49776152406044,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009306,protein secretion,376,0.317709156197346,1.46550747607103,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0010522,regulation of calcium ion transport into cytosol,66,0.541643403722683,2.03126305651419,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030595,leukocyte chemotaxis,138,0.460848872032656,1.90962152227535,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030832,regulation of actin filament length,137,0.422922191485723,1.72585564461608,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032271,regulation of protein polymerization,151,0.399168214240691,1.64113728551943,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032845,negative regulation of homeostatic process,145,0.390373811023555,1.61864819681261,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0033238,regulation of cellular amine metabolic process,75,0.505506469486554,1.89074071592399,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050795,regulation of behavior,171,0.365213412805817,1.55535015398563,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050863,regulation of T cell activation,253,0.331708273562251,1.48614108195763,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051222,positive regulation of protein transport,357,0.29735950876707,1.35497708326556,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1901657,glycosyl compound metabolic process,343,0.310420108350589,1.42503999662922,0.00355871886120996,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002223,stimulatory C-type lectin receptor signaling pathway,118,0.457402953078984,1.85547367235381,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002250,adaptive immune response,299,0.418897401419795,1.90070772217623,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002263,cell activation involved in immune response,176,0.402045455664972,1.72001006794894,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002366,leukocyte activation involved in immune response,175,0.402325956677717,1.71969083211612,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002455,humoral immune response mediated by circulating immunoglobulin,39,0.486863224952271,1.63722081049567,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009119,ribonucleoside metabolic process,309,0.335195761288443,1.52619444045816,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009126,purine nucleoside monophosphate metabolic process,217,0.377172381495876,1.67233945982282,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009167,purine ribonucleoside monophosphate metabolic process,217,0.377172381495876,1.67233945982282,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0019722,calcium-mediated signaling,118,0.371303252405052,1.50730095939749,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045732,positive regulation of protein catabolic process,239,0.353288968974138,1.55216769045453,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050707,regulation of cytokine secretion,126,0.40105100690928,1.64906718025475,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051251,positive regulation of lymphocyte activation,231,0.359234977271386,1.58706649253127,0.00357142857142857,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001959,regulation of cytokine-mediated signaling pathway,118,0.433011481065483,1.74313444946389,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002274,myeloid leukocyte activation,138,0.398652221702058,1.62831085420643,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002698,negative regulation of immune effector process,84,0.422818640004325,1.64494268480304,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009123,nucleoside monophosphate metabolic process,236,0.356113326831804,1.58064267929361,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034341,response to interferon-gamma,138,0.476877462118333,1.95364559747883,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034612,response to tumor necrosis factor,234,0.453626717829275,1.98021872771638,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0046209,nitric oxide metabolic process,66,0.484461560732418,1.73825889262468,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050852,T cell receptor signaling pathway,160,0.436896253114334,1.86430933700988,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060759,regulation of response to cytokine stimulus,124,0.421173264665838,1.70183672000272,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0097529,myeloid leukocyte migration,117,0.40118979237739,1.6227035151012,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1902807,negative regulation of cell cycle G1/S phase transition,97,0.406836896638466,1.57749389487879,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1904950,negative regulation of establishment of protein localization,182,0.400211531609977,1.71281187873718,0.003584229390681,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030168,platelet activation,220,0.503638250340048,2.2083717696254,0.00359712230215827,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032757,positive regulation of interleukin-8 production,38,0.589530688930782,1.94036444541995,0.00359712230215827,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0038179,neurotrophin signaling pathway,347,0.344421542139744,1.58340992474855,0.00359712230215827,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051282,regulation of sequestering of calcium ion,83,0.499920216276261,1.91864651923268,0.00359712230215827,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0070509,calcium ion import,113,0.481617025194087,1.94428023993271,0.00359712230215827,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1900180,regulation of protein localization to nucleus,181,0.361295277393236,1.52526468204708,0.00359712230215827,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002433,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,72,0.516219406248554,1.87049571532411,0.0036101083032491,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0008543,fibroblast growth factor receptor signaling pathway,266,0.322838915122719,1.42346856868289,0.0036101083032491,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009199,ribonucleoside triphosphate metabolic process,200,0.392903301109374,1.71946858856486,0.0036101083032491,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009205,purine ribonucleoside triphosphate metabolic process,194,0.398267112121207,1.73977960132483,0.0036101083032491,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0038096,Fc-gamma receptor signaling pathway involved in phagocytosis,72,0.516219406248554,1.87049571532411,0.0036101083032491,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060401,cytosolic calcium ion transport,98,0.456638809763603,1.80474218409505,0.0036101083032491,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1904029,regulation of cyclin-dependent protein kinase activity,119,0.448460590038058,1.79508443328007,0.0036101083032491,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,78,0.513398140359913,1.88022456345446,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001818,negative regulation of cytokine production,198,0.348577200976551,1.49987912594878,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002220,innate immune response activating cell surface receptor signaling pathway,121,0.479975818306164,1.94092218957414,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002706,regulation of lymphocyte mediated immunity,101,0.455112354422664,1.81696350932131,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006959,humoral immune response,121,0.450866372239282,1.8341782779549,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0019724,B cell mediated immunity,92,0.461467109850239,1.77340847347406,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0046128,purine ribonucleoside metabolic process,284,0.339382305718273,1.53357528575868,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051607,defense response to virus,275,0.365242053462725,1.6320617148427,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0061025,membrane fusion,142,0.3640317257206,1.48890542553374,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0097553,calcium ion transmembrane import into cytosol,84,0.491206407031877,1.88679175019637,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1902656,calcium ion import into cytosol,84,0.491206407031877,1.88679175019637,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,55,0.523943770362884,1.85988546127386,0.0036231884057971,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002685,regulation of leukocyte migration,116,0.472956431834391,1.89627173559603,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007050,cell cycle arrest,227,0.338144761521894,1.5000925066762,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032387,negative regulation of intracellular transport,131,0.416837928900827,1.70610536206689,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032760,positive regulation of tumor necrosis factor production,53,0.514250182759327,1.79859258774028,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045599,negative regulation of fat cell differentiation,31,0.585558073690299,1.88127667080752,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050727,regulation of inflammatory response,218,0.415969890231247,1.78203393703138,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051923,sulfation,11,0.809688686458851,1.94629072443338,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060402,calcium ion transport into cytosol,97,0.469065999061424,1.850130287175,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071346,cellular response to interferon-gamma,117,0.468240339862539,1.85271548649539,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071706,tumor necrosis factor superfamily cytokine production,98,0.472294300562268,1.84962894194132,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903039,positive regulation of leukocyte cell-cell adhesion,184,0.392539608211751,1.69383330783056,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903426,regulation of reactive oxygen species biosynthetic process,58,0.467018154827208,1.64130779828654,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1904589,regulation of protein import,154,0.347492762269167,1.43446948619227,0.00363636363636364,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002385,mucosal immune response,21,0.603248683765691,1.75268497725817,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006595,polyamine metabolic process,75,0.507814010752342,1.90032822023525,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034112,positive regulation of homotypic cell-cell adhesion,183,0.393368490861977,1.69675253513386,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042278,purine nucleoside metabolic process,287,0.337566424489396,1.52475874517315,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0048002,antigen processing and presentation of peptide antigen,180,0.40163329396914,1.71648990944487,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050921,positive regulation of chemotaxis,95,0.444630771862804,1.73328559604479,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051208,sequestering of calcium ion,86,0.495775032448692,1.91214500124505,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051209,release of sequestered calcium ion into cytosol,82,0.500975121125139,1.91158738967005,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051283,negative regulation of sequestering of calcium ion,82,0.500975121125139,1.91158738967005,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051443,positive regulation of ubiquitin-protein transferase activity,92,0.4634049046022,1.79899240312744,0.00364963503649635,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002221,pattern recognition receptor signaling pathway,176,0.351927969603671,1.4919790576743,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002699,positive regulation of immune effector process,137,0.423987426479907,1.76807601343572,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009141,nucleoside triphosphate metabolic process,217,0.35824677845799,1.57774200940058,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0016064,immunoglobulin mediated immune response,89,0.455449100722234,1.74655707097081,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0019882,antigen processing and presentation,219,0.380410050490321,1.66713684943417,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0019884,antigen processing and presentation of exogenous antigen,170,0.387790803344682,1.64883309150374,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0022409,positive regulation of cell-cell adhesion,204,0.386241333899644,1.68438695702338,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032459,regulation of protein oligomerization,26,0.580440645471613,1.7601387001507,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,169,0.393626671578159,1.66452577452979,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0046631,alpha-beta T cell activation,100,0.416237927596898,1.64414702754746,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071356,cellular response to tumor necrosis factor,214,0.484617614361441,2.11059770441315,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071621,granulocyte chemotaxis,76,0.469828770965296,1.78160397530367,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072676,lymphocyte migration,54,0.475462156661888,1.70111065051807,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1901099,negative regulation of signal transduction in absence of ligand,24,0.631307037906132,1.89513847367132,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903650,negative regulation of cytoplasmic transport,106,0.43542490391919,1.71520310419944,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,96,0.409430290562648,1.58143683673694,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,24,0.631307037906132,1.89513847367132,0.00366300366300366,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,44,0.50027622385396,1.7125613871139,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030330,DNA damage response, signal transduction by p53 class mediator,104,0.480145060973449,1.89875008880265,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050870,positive regulation of T cell activation,180,0.391974100185808,1.68088861775661,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051092,positive regulation of NF-kappaB transcription factor activity,112,0.417959798297831,1.66779011463107,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051279,regulation of release of sequestered calcium ion into cytosol,54,0.562701351838788,2.01323922956084,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0055117,regulation of cardiac muscle contraction,44,0.491693013373703,1.67491129488575,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060314,regulation of ryanodine-sensitive calcium-release channel activity,20,0.678990005806691,1.94369354146816,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0090280,positive regulation of calcium ion import,34,0.519972159255536,1.68236093793804,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,96,0.469924369823533,1.83538453944373,0.00367647058823529,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002693,positive regulation of cellular extravasation,11,0.76857960259257,1.83109947062335,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006887,exocytosis,293,0.360497067116262,1.61923677237001,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009144,purine nucleoside triphosphate metabolic process,201,0.377301767340583,1.64986086086589,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042345,regulation of NF-kappaB import into nucleus,44,0.558901033253303,1.87873536820846,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042348,NF-kappaB import into nucleus,44,0.558901033253303,1.87873536820846,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050848,regulation of calcium-mediated signaling,64,0.482647479493569,1.77031745464134,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051924,regulation of calcium ion transport,148,0.403633655866879,1.7021814576217,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1902107,positive regulation of leukocyte differentiation,117,0.38358621803964,1.55994870143173,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903052,positive regulation of proteolysis involved in cellular protein catabolic process,163,0.394679035467125,1.65624866485534,0.003690036900369,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002819,regulation of adaptive immune response,112,0.44685346098372,1.8454867959306,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032612,interleukin-1 production,62,0.424455637104582,1.54421313219096,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0033209,tumor necrosis factor-mediated signaling pathway,156,0.488428039452754,2.03648639655381,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042475,odontogenesis of dentin-containing tooth,54,0.478024212923347,1.694358207744,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042590,antigen processing and presentation of exogenous peptide antigen via MHC class I,78,0.615472143367345,2.34678871008179,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0048011,neurotrophin TRK receptor signaling pathway,345,0.340502175624719,1.5589564070767,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0048520,positive regulation of behavior,108,0.395038218423875,1.55751973048634,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051224,negative regulation of protein transport,173,0.408874921327837,1.73149699132722,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903036,positive regulation of response to wounding,119,0.438198568598645,1.7544088986539,0.0037037037037037,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0000186,activation of MAPKK activity,197,0.392796910622598,1.68239954450592,0.00371747211895911,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002576,platelet degranulation,75,0.58107768595898,2.16293448887779,0.00371747211895911,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034340,response to type I interferon,72,0.542416950173316,2.0236626266993,0.00371747211895911,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050777,negative regulation of immune response,98,0.413605302759658,1.64103611426167,0.00371747211895911,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,90,0.449559469963664,1.75562981687598,0.00371747211895911,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060333,interferon-gamma-mediated signaling pathway,83,0.490733698217075,1.81263810248085,0.00371747211895911,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0090279,regulation of calcium ion import,70,0.525551886644344,1.96804444710541,0.00371747211895911,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001906,cell killing,82,0.506442092751316,1.94055233987774,0.00373134328358209,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0007229,integrin-mediated signaling pathway,77,0.452382949985393,1.67950278791983,0.00373134328358209,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042770,signal transduction in response to DNA damage,120,0.484597695521912,1.95971967786568,0.00373134328358209,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051023,regulation of immunoglobulin secretion,14,0.663732251603344,1.74859527638353,0.00373134328358209,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,32,0.602515278708917,1.86995041799286,0.00373134328358209,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002688,regulation of leukocyte chemotaxis,75,0.506227679573225,1.89616144395118,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042743,hydrogen peroxide metabolic process,35,0.583955398088291,1.90710235663904,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051238,sequestering of metal ion,96,0.497990544666378,1.95458679808485,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051439,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,98,0.43558530034965,1.71913225299888,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0060337,type I interferon signaling pathway,68,0.55829373264222,2.07017127500202,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0070527,platelet aggregation,45,0.5926878109765,2.02422187371455,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071357,cellular response to type I interferon,68,0.55829373264222,2.07017127500202,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0098754,detoxification,70,0.523449786532441,1.95215231669137,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1902105,regulation of leukocyte differentiation,202,0.38081892780728,1.65397402332064,0.00374531835205993,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031145,anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process,85,0.514531724260033,1.96754869607819,0.0037593984962406,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032640,tumor necrosis factor production,94,0.450441895741837,1.73779084906552,0.0037593984962406,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0044774,mitotic DNA integrity checkpoint,104,0.407601457607269,1.60619857251584,0.0037593984962406,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0048013,ephrin receptor signaling pathway,80,0.513144489817348,1.93645037708261,0.0037593984962406,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051495,positive regulation of cytoskeleton organization,160,0.398071728774855,1.65284621863018,0.0037593984962406,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071158,positive regulation of cell cycle arrest,84,0.567694652644101,2.17411771559037,0.0037593984962406,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1990748,cellular detoxification,67,0.526845698711673,1.95233652735575,0.0037593984962406,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006826,iron ion transport,50,0.47502721792327,1.64175144832994,0.00377358490566038,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042088,T-helper 1 type immune response,34,0.55441110957446,1.77245371724378,0.00377358490566038,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045071,negative regulation of viral genome replication,46,0.550295792085168,1.92063964959041,0.00377358490566038,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050709,negative regulation of protein secretion,84,0.413521996770409,1.55215775769231,0.00377358490566038,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051352,negative regulation of ligase activity,98,0.459799012723824,1.81167265633943,0.00377358490566038,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0097530,granulocyte migration,82,0.449748514637984,1.71546863466206,0.00377358490566038,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903364,positive regulation of cellular protein catabolic process,175,0.399999096721585,1.69268981347473,0.00377358490566038,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002285,lymphocyte activation involved in immune response,122,0.423598239892716,1.71894218239785,0.00378787878787879,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002690,positive regulation of leukocyte chemotaxis,63,0.53743114986148,1.9418410066424,0.00378787878787879,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002821,positive regulation of adaptive immune response,69,0.46025194724356,1.73764750165046,0.00378787878787879,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030593,neutrophil chemotaxis,68,0.496166815511244,1.82998136972582,0.00378787878787879,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034381,plasma lipoprotein particle clearance,24,0.580344312217361,1.7128517868352,0.00378787878787879,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042107,cytokine metabolic process,98,0.407498539745463,1.56651206050128,0.00378787878787879,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002479,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,74,0.626387424957612,2.34475365337585,0.00380228136882129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002687,positive regulation of leukocyte migration,87,0.548592347197745,2.10109227615854,0.00380228136882129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0030316,osteoclast differentiation,72,0.443509905597116,1.6736961292863,0.00380228136882129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0046034,ATP metabolic process,181,0.413831053487078,1.77292804033444,0.00380228136882129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051444,negative regulation of ubiquitin-protein transferase activity,97,0.455847804842824,1.7924094499607,0.00380228136882129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,48,0.475600858392466,1.63457507234581,0.00380228136882129,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001909,leukocyte mediated cytotoxicity,72,0.532809417978771,1.97948306409528,0.00381679389312977,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006521,regulation of cellular amino acid metabolic process,60,0.593231919900242,2.0908352647766,0.00381679389312977,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042454,ribonucleoside catabolic process,23,0.608532760507999,1.81654961268997,0.00381679389312977,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050427,3'-phosphoadenosine 5'-phosphosulfate metabolic process,15,0.68024791479757,1.74939151549771,0.00381679389312977,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0050851,antigen receptor-mediated signaling pathway,194,0.404221021741337,1.73493009330205,0.00381679389312977,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2000045,regulation of G1/S transition of mitotic cell cycle,134,0.388227575345414,1.56883208025643,0.00381679389312977,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2000058,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,94,0.475169384618481,1.86021868783757,0.00381679389312977,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002718,regulation of cytokine production involved in immune response,52,0.519317813680636,1.84458299624717,0.00383141762452107,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006977,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,63,0.590882299762213,2.14817292776999,0.00383141762452107,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031571,mitotic G1 DNA damage checkpoint,73,0.521103716767726,1.94292728713914,0.00383141762452107,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,73,0.522777467828868,1.9389770423487,0.00383141762452107,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0001912,positive regulation of leukocyte mediated cytotoxicity,29,0.56497302350115,1.75790746730333,0.00384615384615385,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0006734,NADH metabolic process,34,0.579627829151505,1.90206266306231,0.00384615384615385,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0032680,regulation of tumor necrosis factor production,93,0.456801279543909,1.75809292456458,0.00384615384615385,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042742,defense response to bacterium,138,0.424634616075326,1.76194667014773,0.00384615384615385,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0048525,negative regulation of viral process,81,0.444011368466779,1.7131973064224,0.00384615384615385,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0070555,response to interleukin-1,92,0.461179091770658,1.80012041875209,0.00384615384615385,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0000041,transition metal ion transport,90,0.445789488096962,1.70263970017722,0.00386100386100386,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,102,0.438563114593871,1.76588236970118,0.00386100386100386,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031398,positive regulation of protein ubiquitination,168,0.401497138497182,1.70290647440721,0.00386100386100386,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903901,negative regulation of viral life cycle,79,0.436675714993309,1.67315353149916,0.00386100386100386,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1990266,neutrophil migration,73,0.495860846106108,1.85252536453738,0.00386100386100386,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:2000060,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,85,0.51837186276854,1.99518368367795,0.00386100386100386,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002707,negative regulation of lymphocyte mediated immunity,29,0.624553755511604,1.966852804379,0.00387596899224806,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0098869,cellular oxidant detoxification,64,0.536767104102095,1.97782286951036,0.00387596899224806,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002367,cytokine production involved in immune response,62,0.476747754670732,1.73879774639203,0.00389105058365759,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002637,regulation of immunoglobulin production,41,0.521330093031343,1.73320940542101,0.00389105058365759,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0044783,G1 DNA damage checkpoint,74,0.516680635695317,1.9326793473303,0.00389105058365759,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051926,negative regulation of calcium ion transport,32,0.550524214565007,1.78706954714353,0.00389105058365759,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0051928,positive regulation of calcium ion transport,73,0.465654428841168,1.77178085961215,0.00389105058365759,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002286,T cell activation involved in immune response,67,0.52669588631547,1.95420018365446,0.00390625,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002440,production of molecular mediator of immune response,134,0.408338307819473,1.66524435740258,0.00390625,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0070098,chemokine-mediated signaling pathway,54,0.550739305043437,1.96011657507804,0.00390625,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071156,regulation of cell cycle arrest,103,0.477799494295365,1.90335371624872,0.00390625,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002700,regulation of production of molecular mediator of immune response,88,0.47983729862598,1.8539965349707,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002704,negative regulation of leukocyte mediated immunity,38,0.57258383960121,1.89513281935918,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0035710,CD4-positive, alpha-beta T cell activation,58,0.506869833636709,1.82026192929616,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0044773,mitotic DNA damage checkpoint,99,0.420604015761662,1.63130720238615,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0071243,cellular response to arsenic-containing substance,14,0.743978557526157,1.95001962521967,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072395,signal transduction involved in cell cycle checkpoint,68,0.564768265528575,2.0840847559225,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072401,signal transduction involved in DNA integrity checkpoint,68,0.564768265528575,2.0840847559225,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,66,0.569642506758341,2.09712984611874,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072422,signal transduction involved in DNA damage checkpoint,68,0.564768265528575,2.0840847559225,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,64,0.587322030895329,2.14110483643258,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,64,0.587322030895329,2.14110483643258,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,66,0.569642506758341,2.09712984611874,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,66,0.569642506758341,2.09712984611874,0.00392156862745098,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002292,T cell differentiation involved in immune response,48,0.539650629572038,1.88254175280101,0.00393700787401575,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0010880,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,20,0.646350877163921,1.87760241790282,0.00395256916996047,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031570,DNA integrity checkpoint,156,0.346851842636547,1.45173594128777,0.00395256916996047,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042035,regulation of cytokine biosynthetic process,86,0.420638993928251,1.57632411599136,0.00395256916996047,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0042093,T-helper cell differentiation,41,0.586442019025668,1.97283092182629,0.00395256916996047,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0044819,mitotic G1/S transition checkpoint,74,0.518716891257479,1.93529893189952,0.00395256916996047,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0010501,RNA secondary structure unwinding,41,-0.584859373891885,-2.02654897840444,0.00396825396825397,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0031146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,21,0.642482879238558,1.83040243385655,0.00396825396825397,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0043367,CD4-positive, alpha-beta T cell differentiation,52,0.503684896265938,1.77956802244386,0.00396825396825397,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0045622,regulation of T-helper cell differentiation,23,0.593775169320594,1.78452473021609,0.00396825396825397,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002287,alpha-beta T cell activation involved in immune response,43,0.577375795378727,1.97203352770617,0.004,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002293,alpha-beta T cell differentiation involved in immune response,43,0.577375795378727,1.97203352770617,0.004,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0002294,CD4-positive, alpha-beta T cell differentiation involved in immune response,43,0.577375795378727,1.97203352770617,0.004,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:1903322,positive regulation of protein modification by small protein conjugation or removal,181,0.382082568952937,1.61005150162987,0.004,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0048305,immunoglobulin secretion,18,0.626537737103536,1.7214432328416,0.00401606425702811,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0033539,fatty acid beta-oxidation using acyl-CoA dehydrogenase,17,-0.65275465303426,-1.78751759576391,0.00403225806451613,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072539,T-helper 17 cell differentiation,12,0.7899294497783,1.90675583985249,0.00403225806451613,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0009164,nucleoside catabolic process,31,0.570407642711691,1.80165036969372,0.00404858299595142,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0010043,response to zinc ion,37,0.552773112605092,1.85055527042948,0.00404858299595142,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0019395,fatty acid oxidation,84,-0.409457832690517,-1.58515500348706,0.00404858299595142,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0072538,T-helper 17 type immune response,13,0.754597721077574,1.85008480950441,0.00404858299595142,0.0487020719218862,0.0402664794875973,BP,mono-sp-vs-rr
GO:0034453,microtubule anchoring,16,-0.669458551542099,-1.83252510785147,0.00408163265306122,0.0489795918367347,0.0404959307104646,BP,mono-sp-vs-rr
GO:0050830,defense response to Gram-positive bacterium,53,0.479715304303782,1.66580327964155,0.00413223140495868,0.0494658335013102,0.0408979513892573,BP,mono-sp-vs-rr
GO:0003143,embryonic heart tube morphogenesis,39,-0.505615288472472,-1.70522355508515,0.004149377593361,0.0495502316988218,0.0409677311369103,BP,mono-sp-vs-rr
GO:0071166,ribonucleoprotein complex localization,91,-0.369149711773061,-1.45538517468292,0.00420168067226891,0.0500214028007093,0.0413572915962627,BP,mono-sp-vs-rr
GO:0050657,nucleic acid transport,151,-0.35806816249391,-1.53844352003876,0.00421940928270042,0.0500214028007093,0.0413572915962627,BP,mono-sp-vs-rr
GO:0050658,RNA transport,151,-0.35806816249391,-1.53844352003876,0.00421940928270042,0.0500214028007093,0.0413572915962627,BP,mono-sp-vs-rr
GO:0051236,establishment of RNA localization,154,-0.355058867958203,-1.52209707503827,0.00423728813559322,0.0500841879687739,0.041409201865831,BP,mono-sp-vs-rr
GO:0061371,determination of heart left/right asymmetry,36,-0.505265144096849,-1.64508700875717,0.00425531914893617,0.0500841879687739,0.041409201865831,BP,mono-sp-vs-rr
GO:0070989,oxidative demethylation,13,-0.728074201058641,-1.83987879645752,0.00425531914893617,0.0500841879687739,0.041409201865831,BP,mono-sp-vs-rr
GO:0071426,ribonucleoprotein complex export from nucleus,88,-0.382520336234589,-1.50611836581699,0.00431034482758621,0.0506104603200792,0.0418443195929107,BP,mono-sp-vs-rr
GO:0007368,determination of left/right symmetry,77,-0.473232706544877,-1.81122520916596,0.00440528634361234,0.0516017789366333,0.0426639338139067,BP,mono-sp-vs-rr
GO:0006403,RNA localization,184,-0.353641751719169,-1.54229120851875,0.00442477876106195,0.0517067003792667,0.0427506820147714,BP,mono-sp-vs-rr
GO:0021532,neural tube patterning,25,-0.589620890003918,-1.7956477342676,0.00448430493273543,0.0522778351778277,0.043222891650694,BP,mono-sp-vs-rr
GO:0009855,determination of bilateral symmetry,81,-0.454660264935619,-1.75669789088395,0.00452488687782805,0.0526259355364457,0.0435106982140862,BP,mono-sp-vs-rr
GO:0009799,specification of symmetry,82,-0.454605000994988,-1.7562625563013,0.0045662100456621,0.0529809903170439,0.0438042546373707,BP,mono-sp-vs-rr
GO:0042254,ribosome biogenesis,224,-0.336487192992225,-1.51167131098388,0.00495049504950495,0.0573043153371941,0.0473787448258232,BP,mono-sp-vs-rr
GO:0022613,ribonucleoprotein complex biogenesis,361,-0.320772713065189,-1.52670194447971,0.00512820512820513,0.0590827013362225,0.0488490999980993,BP,mono-sp-vs-rr
GO:0034470,ncRNA processing,318,-0.299961037048068,-1.41231516299998,0.00512820512820513,0.0590827013362225,0.0488490999980993,BP,mono-sp-vs-rr
hsa05144,Malaria,37,0.675725123878686,2.22127463840719,0.0034965034965035,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05010,Alzheimer's disease,147,0.410325003967796,1.71556935928825,0.00350877192982456,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04060,Cytokine-cytokine receptor interaction,186,0.390615047128688,1.68369177695026,0.00352112676056338,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05034,Alcoholism,132,0.420073358621925,1.75814476843407,0.00359712230215827,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05110,Vibrio cholerae infection,44,0.483806833323566,1.68815139661433,0.00359712230215827,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa00190,Oxidative phosphorylation,110,0.495609850745084,1.95335022330083,0.0036101083032491,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04721,Synaptic vesicle cycle,48,0.462293329215074,1.60619419956748,0.0036101083032491,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04514,Cell adhesion molecules (CAMs),111,0.405742776287514,1.6314494967735,0.00367647058823529,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05203,Viral carcinogenesis,188,0.434400940563802,1.882121993392,0.00367647058823529,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04650,Natural killer cell mediated cytotoxicity,98,0.417488791938266,1.67624874373652,0.0037037037037037,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05168,Herpes simplex infection,166,0.382537066923641,1.60954367062744,0.0037037037037037,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05016,Huntington's disease,166,0.402687095572467,1.70167105231841,0.00371747211895911,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04668,TNF signaling pathway,102,0.396265523222714,1.5730835605947,0.00373134328358209,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05323,Rheumatoid arthritis,79,0.498005284273402,1.91496976978113,0.00373134328358209,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05152,Tuberculosis,153,0.418984696593327,1.76565546465035,0.00374531835205993,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04145,Phagosome,136,0.469023721582253,1.92992216125069,0.0037593984962406,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04210,Apoptosis,131,0.388773896978808,1.61767568189163,0.00377358490566038,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04610,Complement and coagulation cascades,58,0.446149350764199,1.58355287131901,0.00378787878787879,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04062,Chemokine signaling pathway,156,0.386792626271947,1.62990480235416,0.00380228136882129,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05012,Parkinson's disease,112,0.44861744604466,1.77856656494561,0.00380228136882129,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05169,Epstein-Barr virus infection,194,0.386824219215392,1.68808977275279,0.00380228136882129,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05162,Measles,116,0.425451708886883,1.69621626645162,0.00383141762452107,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05416,Viral myocarditis,55,0.499020142536549,1.77624991508549,0.00384615384615385,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05134,Legionellosis,53,0.596548614240918,2.10614515083944,0.00389105058365759,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05164,Influenza A,149,0.373801086169105,1.5646401996649,0.00389105058365759,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04612,Antigen processing and presentation,65,0.43647346830629,1.59487117640616,0.00393700787401575,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05140,Leishmaniasis,69,0.473207315497126,1.78039151953791,0.00398406374501992,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05130,Pathogenic Escherichia coli infection,46,0.569102942149954,1.94128540495092,0.00403225806451613,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05322,Systemic lupus erythematosus,108,0.433565281440033,1.74634088471706,0.00404858299595142,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa04670,Leukocyte transendothelial migration,93,0.451127486166802,1.77297007628534,0.0040650406504065,0.0382113821138211,0.0306660961346456,KG,mono-sp-vs-rr
hsa05340,Primary immunodeficiency,33,0.571258933192774,1.78735650158012,0.00421940928270042,0.0383152173913043,0.0307494279176201,KG,mono-sp-vs-rr
hsa03050,Proteasome,43,0.683820224898525,2.34451346256577,0.00434782608695652,0.0383152173913043,0.0307494279176201,KG,mono-sp-vs-rr
hsa04144,Endocytosis,234,0.315641551381094,1.39594721616223,0.00687285223367698,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa05132,Salmonella infection,74,0.422941423713366,1.59024162172314,0.00740740740740741,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa00010,Glycolysis / Gluconeogenesis,50,0.474781183460456,1.64498928935664,0.00743494423791822,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa04810,Regulation of actin cytoskeleton,166,0.351359011700456,1.492236602742,0.00757575757575758,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa04966,Collecting duct acid secretion,22,0.644279102828279,1.86796394096542,0.00763358778625954,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa05133,Pertussis,63,0.459563102745309,1.71873603365619,0.00763358778625954,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa04666,Fc gamma R-mediated phagocytosis,84,0.427929682864559,1.64246641851024,0.00778210116731518,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa05100,Bacterial invasion of epithelial cells,70,0.439658047896117,1.63927979837656,0.00796812749003984,0.0561752988047809,0.0450828265883833,KG,mono-sp-vs-rr
hsa05145,Toxoplasmosis,109,0.368086102492919,1.461974466574,0.00840336134453781,0.0577987292477967,0.046385691632237,KG,mono-sp-vs-rr
DOID:1324,lung cancer,463,0.295727683182043,1.39599303373322,0.003125,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:18,urinary system disease,345,0.332712363883053,1.50733344506661,0.00315457413249211,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:0050615,respiratory system cancer,471,0.295858038085949,1.39406409926051,0.00318471337579618,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3905,lung carcinoma,398,0.296938191563778,1.38605638991735,0.00320512820512821,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:557,kidney disease,335,0.34521811499464,1.55992146589883,0.00320512820512821,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:936,brain disease,314,0.317547772206293,1.43909224738914,0.0032258064516129,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:219,colon cancer,238,0.325311033465743,1.44233087807445,0.00325732899022801,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1612,breast cancer,419,0.306974839499589,1.44013433673712,0.00326797385620915,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:5093,thoracic cancer,419,0.306974839499589,1.44013433673712,0.00326797385620915,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:9351,diabetes mellitus,476,0.293121132854794,1.36103421734813,0.00327868852459016,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:10155,intestinal cancer,250,0.319848101727288,1.4176577404848,0.00328947368421053,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:114,heart disease,357,0.30145912528445,1.38392088429419,0.0033003300330033,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2349,arteriosclerosis,272,0.38723365333373,1.7354753670918,0.0033003300330033,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:37,skin disease,250,0.381387109638696,1.68353430501008,0.0033112582781457,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:0070004,myeloma,262,0.356846241229886,1.60287302119007,0.00332225913621262,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2214,inherited blood coagulation disease,14,0.724205666939346,1.87582225710523,0.00332225913621262,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3908,non-small cell lung carcinoma,334,0.293054827599436,1.34808840926423,0.00332225913621262,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1074,kidney failure,111,0.41728926205846,1.67338096842303,0.00333333333333333,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1579,respiratory system disease,410,0.356927047146201,1.6528191625366,0.00333333333333333,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:409,liver disease,495,0.312562925846067,1.45732865203098,0.00333333333333333,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1247,blood coagulation disease,143,0.417531268218744,1.72337426808162,0.00334448160535117,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:5844,myocardial infarction,197,0.348664992323461,1.50002211594078,0.00334448160535117,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:16,integumentary system disease,286,0.350455646453098,1.57175042015666,0.00335570469798658,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:417,hypersensitivity reaction type II disease,458,0.330045949284754,1.536395460857,0.00335570469798658,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:850,lung disease,361,0.360530244590522,1.65397932884637,0.00335570469798658,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:5419,schizophrenia,468,0.318927618678319,1.50089930246202,0.00336700336700337,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2348,arteriosclerotic cardiovascular disease,264,0.387931798402572,1.72932770894477,0.00337837837837838,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2355,anemia,197,0.366321121660235,1.58995406262337,0.00337837837837838,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1883,hepatitis C,198,0.364357503333071,1.55937703021607,0.00338983050847458,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1936,atherosclerosis,263,0.391694447105164,1.744358030891,0.00338983050847458,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:326,ischemia,163,0.347853235431515,1.45682911580224,0.00338983050847458,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2468,psychotic disorder,471,0.319177798965535,1.50062351914191,0.00340136054421769,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3083,chronic obstructive pulmonary disease,166,0.406254068374906,1.70938158282981,0.00340136054421769,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:4960,bone marrow cancer,267,0.352594158091183,1.57821537254268,0.00340136054421769,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:7148,rheumatoid arthritis,433,0.354334900633398,1.64937620487354,0.00340136054421769,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2213,hemorrhagic disease,126,0.414322909412268,1.69000353740571,0.00341296928327645,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2237,hepatitis,358,0.340060843253075,1.54299777738851,0.00341296928327645,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:4905,pancreatic carcinoma,184,0.34371877811913,1.46613699412041,0.00341296928327645,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:201,connective tissue cancer,300,0.310756531662146,1.41865290279112,0.00342465753424658,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:5041,esophageal cancer,111,0.382314088410819,1.52035791138356,0.00342465753424658,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:5082,liver cirrhosis,169,0.368762563752787,1.55610374510439,0.00342465753424658,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:10952,nephritis,116,0.445364397667898,1.7740184293079,0.00343642611683849,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:28,endocrine system disease,278,0.363094431376398,1.60360125758803,0.00343642611683849,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:74,hematopoietic system disease,377,0.356585459972231,1.62960165419281,0.00343642611683849,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:9352,type 2 diabetes mellitus,154,0.392789545755908,1.61333277961497,0.00343642611683849,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2218,blood platelet disease,80,0.452505126845478,1.71160013929523,0.00344827586206897,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:0050161,lower respiratory tract disease,369,0.368759454889442,1.68624819215683,0.00346020761245675,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:0060100,musculoskeletal system cancer,354,0.30250354649992,1.38629694305858,0.00346020761245675,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3388,periodontal disease,100,0.471415003604326,1.84807144989101,0.00346020761245675,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:0050589,inflammatory bowel disease,61,0.509709758503508,1.84714979597792,0.00347222222222222,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3213,demyelinating disease,137,0.430988126345531,1.75744408448668,0.00347222222222222,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1485,cystic fibrosis,107,0.389119174635215,1.53925516474473,0.0034965034965035,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2377,multiple sclerosis,134,0.428562995184019,1.74079254276551,0.0034965034965035,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:10591,pre-eclampsia,194,0.373230954792303,1.58957315549246,0.00350877192982456,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:9970,obesity,222,0.335638086441621,1.44347509232782,0.00350877192982456,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1588,thrombocytopenia,57,0.514292409566424,1.83900656590877,0.00354609929078014,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3393,coronary artery disease,245,0.343664635609789,1.49814236476113,0.00354609929078014,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:715,T-cell leukemia,53,0.540100308805198,1.9438406052264,0.00354609929078014,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2841,asthma,93,0.418188119712533,1.6339135797997,0.00355871886120996,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:8778,Crohn's disease,34,0.559409021332979,1.84874949952516,0.00355871886120996,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:0060058,lymphoma,64,0.437138953125082,1.61622050092416,0.00357142857142857,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1091,tooth disease,110,0.468871925207401,1.87001744434463,0.00357142857142857,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2723,dermatitis,133,0.447941056263064,1.84926848483299,0.00357142857142857,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:824,periodontitis,87,0.473143586577085,1.82088731548335,0.003584229390681,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2320,obstructive lung disease,223,0.40515786304974,1.74411296721131,0.00359712230215827,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:403,mouth disease,131,0.451285265103299,1.85096630471107,0.00359712230215827,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:526,Human immunodeficiency virus infectious disease,144,0.444471685048201,1.84938791096769,0.0036101083032491,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2789,parasitic protozoa infectious disease,102,0.460015794973607,1.80025241804988,0.00363636363636364,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:4989,pancreatitis,84,0.531833620806049,1.96580425451862,0.00363636363636364,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:26,pancreas disease,119,0.477920108678936,1.88286413919085,0.00364963503649635,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1176,bronchial disease,106,0.443551686041256,1.74676240781901,0.00366300366300366,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:5295,intestinal disease,98,0.492045453527506,1.92671542627761,0.00366300366300366,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:10747,lymphoid leukemia,60,0.507659451786266,1.8733434359132,0.00367647058823529,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2916,hypersensitivity reaction type IV disease,68,0.470131855589936,1.69635348263502,0.00367647058823529,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:576,proteinuria,50,0.498279207509725,1.71899524822138,0.00367647058823529,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1712,aortic valve stenosis,15,0.717098224206095,1.90082148254289,0.003690036900369,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:612,primary immunodeficiency disease,164,0.399344639000024,1.65680862064677,0.003690036900369,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:784,chronic kidney failure,49,0.529470050181938,1.82015208623546,0.0037037037037037,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3454,brain infarction,43,0.493588324707591,1.65428863706842,0.00371747211895911,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:811,lipodystrophy,28,0.641263286731989,1.96890181075969,0.00371747211895911,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3310,atopic dermatitis,102,0.438584908560787,1.73294057503031,0.00373134328358209,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:4971,myelofibrosis,37,0.557630044489083,1.83648761768505,0.00373134328358209,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:865,vasculitis,99,0.511194604370709,1.99231647276352,0.00373134328358209,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:104,bacterial infectious disease,221,0.434637589195475,1.90765885941451,0.00374531835205993,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1123,spondyloarthropathy,57,0.494223587888628,1.72859739299751,0.00374531835205993,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:10603,glucose intolerance,37,0.503622919262274,1.65858157707259,0.0037593984962406,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:12365,malaria,86,0.469153185105982,1.77006992270328,0.00377358490566038,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:583,hemolytic anemia,46,0.569298499359686,1.94356350473593,0.00377358490566038,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:720,normocytic anemia,46,0.569298499359686,1.94356350473593,0.00377358490566038,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:381,arthropathy,70,0.455742573728719,1.65376733000848,0.00378787878787879,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1555,urticaria,35,0.585851507152405,1.89042021257453,0.00380228136882129,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:11077,brucellosis,38,0.565449491078756,1.84083171913562,0.00381679389312977,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:11714,gestational diabetes,43,0.539603652613005,1.78616689950989,0.00381679389312977,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:13378,Kawasaki disease,42,0.561229804899677,1.87379389894757,0.00381679389312977,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:399,tuberculosis,123,0.479353720687858,1.94238560116956,0.00381679389312977,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:0050338,primary bacterial infectious disease,193,0.438716216971715,1.88578065316962,0.00383141762452107,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:11729,Lyme disease,14,0.700541978910351,1.77675807065101,0.00383141762452107,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:2921,glomerulonephritis,57,0.485773606457874,1.70667682979296,0.00384615384615385,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:14069,cerebral malaria,18,0.669431381884422,1.8809476039496,0.00386100386100386,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:75,lymphatic system disease,82,0.458004874439563,1.74201627983295,0.00387596899224806,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:6364,migraine,45,0.576068043478016,1.9656214636467,0.00389105058365759,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:1602,lymphadenitis,46,0.579538454483532,1.96860700839895,0.00390625,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:9942,lymph node disease,46,0.579538454483532,1.96860700839895,0.00390625,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:4481,allergic rhinitis,68,0.458448553535152,1.69352669615182,0.00392156862745098,0.0272247360482655,0.0186552353735016,DO,mono-sp-vs-rr
DOID:3480,uveal disease,36,0.560412044385,1.80679597841417,0.00396825396825397,0.0272452830188679,0.018669314796425,DO,mono-sp-vs-rr
DOID:13241,Behcet's disease,69,0.537494060223202,1.97376109383464,0.004,0.0272452830188679,0.018669314796425,DO,mono-sp-vs-rr
DOID:4248,coronary stenosis,13,0.76034090789654,1.94939876104561,0.00404858299595142,0.0273184759166068,0.0187194688450287,DO,mono-sp-vs-rr
DOID:170,endocrine gland cancer,392,0.297068513754939,1.36974117286232,0.00638977635782748,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:10652,Alzheimer's disease,335,0.304832432005329,1.37748102181672,0.00655737704918033,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:5672,large intestine cancer,242,0.323682514447209,1.43565824167858,0.00655737704918033,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:10763,hypertension,405,0.28783470291367,1.34263640168721,0.00657894736842105,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:9256,colorectal cancer,241,0.323704733462511,1.43513988349055,0.00657894736842105,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:10534,stomach cancer,203,0.330133727383697,1.43769912037202,0.00675675675675676,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:3498,pancreatic ductal adenocarcinoma,81,0.414743239009178,1.56341649169905,0.00675675675675676,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:1107,esophageal carcinoma,94,0.39215173218647,1.51917684296116,0.00680272108843537,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:1793,pancreatic cancer,245,0.333149741359217,1.45738963728869,0.00680272108843537,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:654,overnutrition,228,0.333692476856022,1.43936369866527,0.0068259385665529,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:374,nutrition disease,238,0.324322352419842,1.40427900648223,0.00684931506849315,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:0060180,colitis,46,0.523470613050724,1.77298998949045,0.00687285223367698,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:8577,ulcerative colitis,46,0.523470613050724,1.77298998949045,0.00687285223367698,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:1037,lymphoblastic leukemia,347,0.303585442711136,1.38527191677124,0.00694444444444444,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:3082,interstitial lung disease,121,0.372711355355226,1.50974557037995,0.0072463768115942,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:4195,hyperglycemia,106,0.389793137486732,1.55226207062193,0.0072463768115942,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:6713,cerebrovascular disease,81,0.431824214845896,1.64084628254774,0.0072992700729927,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:9074,systemic lupus erythematosus,65,0.469305185481747,1.72155054731105,0.0072992700729927,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:0060031,autoimmune disease of gastrointestinal tract,86,0.426198564739169,1.62710004250823,0.00732600732600733,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:8857,lupus erythematosus,68,0.480712388210511,1.7762254748096,0.00732600732600733,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:5223,infertility,142,0.355063847946961,1.46386122808489,0.00738007380073801,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:974,upper respiratory tract disease,88,0.406914036012214,1.57096241218699,0.00749063670411985,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:4851,pilocytic astrocytoma,11,-0.692406623591342,-1.65333978190142,0.0075187969924812,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:3770,pulmonary fibrosis,90,0.394016322870784,1.50418142148731,0.00757575757575758,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:4676,uremia,14,0.69132995353517,1.77426212371296,0.00760456273764259,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:76,stomach disease,53,0.449154840597144,1.59452015342761,0.00760456273764259,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:6590,spondylitis,50,0.485580332414845,1.65247693479572,0.00769230769230769,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:7147,ankylosing spondylitis,50,0.485580332414845,1.65247693479572,0.00769230769230769,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:12894,Sjogren's syndrome,61,0.425595756383256,1.52052265173124,0.00772200772200772,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:4029,gastritis,45,0.470155099327434,1.60245610104988,0.00778210116731518,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:627,severe combined immunodeficiency,38,0.535133415796915,1.72386618103204,0.00778210116731518,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:9588,encephalitis,45,0.48036759122974,1.63048909457514,0.0078740157480315,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:986,alopecia areata,23,0.647045791754082,1.92734154473913,0.0078740157480315,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:13141,uveitis,24,0.583638278186668,1.7149892280929,0.00790513833992095,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:2163,nasal cavity disease,69,0.458433901981508,1.68962640907398,0.00793650793650794,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:2825,nose disease,69,0.458433901981508,1.68962640907398,0.00793650793650794,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:4483,rhinitis,69,0.458433901981508,1.68962640907398,0.00793650793650794,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:628,combined T cell and B cell immunodeficiency,39,0.55895415920985,1.79506222333951,0.00796812749003984,0.0396757796400604,0.0271870774614789,DO,mono-sp-vs-rr
DOID:0050737,autosomal recessive disease,257,0.308852456077549,1.36791814241189,0.0102739726027397,0.0503007361649753,0.0344676279305123,DO,mono-sp-vs-rr
DOID:3978,extrinsic cardiomyopathy,23,0.595595616780625,1.79580059985042,0.0103806228373702,0.0503007361649753,0.0344676279305123,DO,mono-sp-vs-rr
DOID:820,myocarditis,23,0.595595616780625,1.79580059985042,0.0103806228373702,0.0503007361649753,0.0344676279305123,DO,mono-sp-vs-rr
DOID:9538,multiple myeloma,217,0.332298635012759,1.45074391265472,0.0103806228373702,0.0503007361649753,0.0344676279305123,DO,mono-sp-vs-rr
DOID:1036,chronic leukemia,179,0.311392909638665,1.35510361308918,0.0106382978723404,0.0512056737588652,0.0350877192982456,DO,mono-sp-vs-rr
DOID:866,vein disease,34,0.514585234882428,1.62997597536493,0.0109489051094891,0.0520923520923521,0.0356952988531936,DO,mono-sp-vs-rr
DOID:11335,sarcoidosis,64,0.441203282953111,1.58814792817539,0.0110294117647059,0.0520923520923521,0.0356952988531936,DO,mono-sp-vs-rr
DOID:62,aortic valve disease,19,0.661484174169929,1.85536617610213,0.011070110701107,0.0520923520923521,0.0356952988531936,DO,mono-sp-vs-rr
DOID:1686,glaucoma,81,0.404099014678451,1.54768287218205,0.0111111111111111,0.0520923520923521,0.0356952988531936,DO,mono-sp-vs-rr
DOID:1398,parasitic infectious disease,120,0.423084643530282,1.67415794375543,0.0115830115830116,0.0533418706595085,0.036551507814505,DO,mono-sp-vs-rr
DOID:0050851,glomerulosclerosis,18,0.607781142596734,1.68688727844111,0.0116731517509728,0.0533418706595085,0.036551507814505,DO,mono-sp-vs-rr
DOID:1312,focal segmental glomerulosclerosis,18,0.607781142596734,1.68688727844111,0.0116731517509728,0.0533418706595085,0.036551507814505,DO,mono-sp-vs-rr
DOID:200,giant cell tumor,15,0.657428982228467,1.71732872558792,0.0116731517509728,0.0533418706595085,0.036551507814505,DO,mono-sp-vs-rr
DOID:783,end stage renal failure,27,0.55892685716415,1.69916720631479,0.0118110236220472,0.0536324468875353,0.036750619678002,DO,mono-sp-vs-rr
DOID:3459,breast carcinoma,312,0.28995577558604,1.3297376833439,0.0128617363344051,0.0580385852090032,0.0397698426129633,DO,mono-sp-vs-rr
DOID:680,tauopathy,338,0.302096343445746,1.36609292852081,0.0131147540983607,0.0588127481926484,0.0403003231528572,DO,mono-sp-vs-rr
DOID:10825,essential hypertension,79,0.383031852053931,1.47615906122319,0.0142857142857143,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:987,alopecia,45,0.43230543267537,1.52467586390729,0.0142857142857143,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:1564,fungal infectious disease,62,0.423639073634236,1.56737153856543,0.0144927536231884,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:15,reproductive system disease,258,0.301735754450906,1.34098682441887,0.0145454545454545,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:10608,celiac disease,71,0.426974915579743,1.5749856378774,0.0147058823529412,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:4896,bile duct adenocarcinoma,93,0.372377871643666,1.45935905625466,0.0147058823529412,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:4947,cholangiocarcinoma,93,0.372377871643666,1.45935905625466,0.0147058823529412,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:50,thyroid gland disease,128,0.353635468157139,1.43794106818836,0.0148148148148148,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:2228,thrombocytosis,29,0.547749350319662,1.64951101028084,0.0148698884758364,0.0631532910561994,0.0432745980411339,DO,mono-sp-vs-rr
DOID:9553,adrenal gland disease,29,0.511795482692129,1.56617207813373,0.0151515151515152,0.063973063973064,0.0438363319249746,DO,mono-sp-vs-rr
DOID:6000,congestive heart failure,149,0.335942377784631,1.38147238394143,0.0167785234899329,0.0704307788356485,0.048261358875572,DO,mono-sp-vs-rr
DOID:0060085,organ system benign neoplasm,186,0.323975502597542,1.39258401633633,0.0173010380622837,0.0722043322599356,0.0494766528096949,DO,mono-sp-vs-rr
